Institutional investors purchased a net $1.6 million shares of RMD during the quarter ended March 2017 and now own 64.58% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH (... Bought 923.1 Thousand shares of ResMed Inc
MORGAN STANLEY & CO. LLC Bought 522.2 Thousand shares of ResMed Inc
THE VANGUARD GROUP, INC. Bought 508.4 Thousand shares of ResMed Inc